Please provide your email address to receive an email when new articles are posted on . High FeNO levels indicate exacerbation and lung function risks. Most patients with high FeNO levels also had ...

For decades, scientists believed molecules called leukotrienes were the main culprits behind asthma’s airway-constricting ...

Please provide your email address to receive an email when new articles are posted on . 6.5% of patients with mild asthma had at least one acute exacerbation in the year after the index date.

With the inclusion of the BATURA study, Airsupra has now demonstrated its effectiveness in reducing the risk of severe exacerbations across all severity levels of asthma vs albuterol. The Food and ...

Severe exacerbation occurred in 5.1% of patients taking albuterol/budesonide compared with 9.1% of patients taking albuterol alone in the on-treatment efficacy population. Albuterol/budesonide ...

In children aged 5 to 15 years with mild asthma, budesonide-formoterol reliever monotherapy is superior to salbutamol for preventing asthma attacks.

Six grantees of the ACAAI Community Grant Projects will share their project outcomes at the ACAAI Annual Scientific Meeting ...

DENVER — National Jewish Health researchers are looking for ways to identify patients with untreated mild persistent asthma who might benefit from daily inhaled treatment based on inflammatory ...

Mild asthma could be better treated with the recent approval of the combination of albuterol/budesonide. The recent approval of albuterol/budesonide could change the way that mild asthma is treated in ...

People with mild asthma may not need daily medicine to prevent flare-ups, as doctors now recommend. A study found that patients who take medicine only when asthma attacks occur fare about as well as ...

For decades, scientists have thought they understood the biochemical machinery that causes asthma—inflammation in the lungs ...